The Journal is included in Russian and International Library and Abstract Databases
Russain Science Index (Russia)
EBSCO
DOI Registration Agency (USA)

A differentiated approach to assessing ventricular ectopic activity: for whom sustained-release lappaconitine hydrobromide is indicated

DOI: https://doi.org/10.29296/25877305-2020-06-16
Issue: 
6
Year: 
2020

V. Frolov, Candidate of Medical Sciences Medical Center for Premorbid and Emergency Conditions, P.V. Mandryka Central Military Clinical Hospital, Moscow

Objective: to select those, for whom the treatment with sustained-release lappaconitine hydrobromide (Allaforte®) is indicated, among the patients with high ventricular ectopic activity; to study the antiarrhythmic efficacy of the drug in patients with various non-coronarogenic diseases; to analyze the role of instrumental studies in the evaluation of ventricular arrhythmias and their importance in monitoring the efficiency of performed therapy.

Keywords: 
кардиология
аритмии
желудочковая эктопическая активность
лаппаконитина гидробромид
Аллафорте®
эффективность
побочные действия
вариабельность сердечного ритма



References: 
  1. Kushakovskij M.S. Aritmii serdtsa. SPb: Foliant 2004; c. 226–7 [Kushakovskii M.S. Aritmii serdtsa. SPb: Foliant 2004; c. 226–7 (in Russ.)].
  2. Shomahov R.A., Makarenko V.N., Bokerija L.A. Evoljutsija metodov diagnostiki i prognozirovanija nekoronarogennyh zheludochkovyh aritmij. Kreativnaja kardiologija. 2014; 2: 36–47 [Shomakhov R.A., Makarenko V.N., Bockeria L.A. Evolution of diagnostic methods and prediction of noncoronary ventricular arrhythmias. Creative Cardiology. 2014; 2: 36–47 (in Russ.)].
  3. Treshkur T.V. Differentsirovannyj podhod k lecheniju zheludochkovyh aritmij. Doktor.Ru. 2008; 3: 14–9 [Treshkur T.V. Differentsirovannyi podkhod k lecheniyu zheludochkovykh aritmii. Doktor.Ru. 2008; 3: 14–9 (in Russ.)].
  4. Golitsyn S.P. Ustranenie zheludochkovyh aritmij i snizhenie riska smerti: vsegda li puti v odnom napravlenii? Serdtse. 2006; 5 (1): 4–11 [Golitsyn S.P. Ustranenie zheludochkovykh aritmii i snizhenie riska smerti: vsegda li puti v odnom napravlenii? Serdtse. 2006; 5 (1): 4–11 (in Russ.)].
  5. Rukovodstvo po narushenijam ritma serdtsa. Pod red. E.I. Chazova, S.P. Golitsyna. M.: GEOTAR-Media, 2008; 416 s. [Rukovodstvo po narusheniyam ritma serdtsa. Pod red. E.I. Chazova, S.P. Golitsyna. M.: GEOTAR-Media, 2008; 416 s. (in Russ.)].
  6. Bigger J.T. Identification of patients high risk for sudden cardiak death. Am J Cardiol. 1984; 54: 3D–8D. DOI: 10.1016/s0002-9149(84)80277-5
  7. Nedostup A.V., Blagova O.V. Kak lechit' aritmii. Diagnostika i terapija narushenij ritma i provodimosti v klinicheskoj praktike. M.: MEDpress-inform, 2006; 288 s. [Nedostup A.V., Blagova O.V. Kak lechit’ aritmii. Diagnostika i terapiya narushenii ritma i provodimosti v klinicheskoi praktike. M.: MEDpress-inform, 2006; 288 s. (in Russ.)].
  8. Sokolov S.F., Beljaeva M.M., Bakalov S.A. i dr. Lappakonitina gidrobromid i ego prolongirovannaja forma pri zheludochkovoj ekstrasistolii u bol'nyh bez organicheskoj patologii serdtsa: effektivnost' i bezopasnost'. Kardiologija: novosti, mnenija, obuchenie. 2018; 6 (2): 29–37 [Sokolov S.F., Belyaeva M.M., Bakalov S.A. et al. Lappaconitine hydrobromide and its sustained-release form in case of ventricular premature beats in patients without organic heart diseases: efficiency and safety. Kardiologiya: novosti, mneniya, obuchenie. 2018; 6 (2): 29–37 (in Russ.)]. DOI: 10.24411/2309-1908-2018-12004
  9. Sokolov S.F. Allapinin i prolongirovannaja forma lappakonitina gidro-bromida – allaforte. Sovremennye podhody k lecheniju narushenij ritma serdtsa. Metodicheskie rekomendatsii po primeneniju preparata. M., 2018; 45 s. [Sokolov S.F. Allapinin i prolongirovannaya forma lappakonitina gidro-bromida – allaforte. Sovremennye podkhody k lecheniyu narushenii ritma serdtsa. Metodicheskie rekomendatsii po primeneniyu preparata. M., 2018; 45 s. (in Russ.)].
  10. Doschitsyn V.L. Printsipy i taktika medikamentoznoj terapii aritmij serdtsa. Vrach. 2001; 1: 19–20 [Doshchitsyn V.L. Printsipy i taktika medikamentoznoi terapii aritmii serdtsa. Vrach. 2001; 1: 19–20 (in Russ.)].
  11. Doschitsyn V.L. Antiaritmicheskie preparaty. 1S klass: aktual'nye voprosy. Effektivnaja farmakoterapija v kardiologii i angiologii. 2007; 1: 32 [Doshchitsyn V.L. Antiaritmicheskie preparaty. 1S klass: aktual’nye voprosy. Effektivnaya farmakoterapiya v kardiologii i angiologii. 2007; 1: 32 (in Russ.)].
  12. Shljahto E.V., Treshkur T.V., Parmon E.V. i dr. Idiopaticheskie zheludochkovye narushenija ritma: rezul'taty prospektivnogo nabljudenija. Vestnik aritmologii. 2003; 33: 5–11 [Shlyakhto E.V., Treshkur T.V., Parmon E.V. et al. Idiopathic ventricular arrhythmias: data of long-term follow-up. Vestnik aritmologii. 2003; 33: 5–11 (in Russ.)].
  13. Abdin A.A., Mazur N.A., Nazarenko V.A. Sravnenie effektivnosti i algoritmy podbora antiaritmicheskih preparatov I klassa u bol'nyh s zheludochkovymi narushenijami ritma. Kardiologija. 1991; 6: 22–5 [Abdin A.A., Mazur N.A., Nazarenko V.A. Sravnenie effektivnosti i algoritmy podbora antiaritmicheskikh preparatov I klassa u bol’nykh s zheludochkovymi narusheniyami ritma. Kardiologiya. 1991; 6: 22–5 (in Russ.)].
  14. Bigger J.T., Sahar D.I. Clinical Types of Proarrhythmic Ressponse to Antiarrhythmic Drugs. Am J Cardiol. 1987; 59: 2E–9F. DOI: 10.1016/0002-9149(87)90195-0
  15. Blagova O.V., Nedostup A.V. Sovremennye maski miokardita (ot klinicheskih sindromov k diagnozu). Rossijskij kardiologicheskij zhurnal. 2014; 5: 13–22 [Blagova O.V., Nedostup A.V. Contemporary masks of the myocarditis (from clinical signs to diagnosis). Russian Journal of Cardiology. 2014; 5: 13–22 (in Russ.)]. https://doi.org/10.15829/1560-4071-2014-5-13-22